Gilead Sciences, Inc. · NASDAQ:GILD

O'Day Daniel Patrick sold 30,881 Gilead Sciences, Inc. shares (Form 4)

Traded Oct 30 to Nov 2, 2026 · Filed Nov 2, 2026

From Oct 30 to Nov 2, 2026, O'Day Daniel Patrick (Director, Chairman & CEO) sold 30,881 Gilead Sciences, Inc. shares at an average US$172.57 for US$5.33M under a trading plan, leaving 551,683 shares. Filed Nov 2, 2026 (Form 4).

Sold
30,881 shares
Price
US$172.57 average (US$167.40 to US$175.25)
Value
US$5.33M
Holding after
551,683 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairman & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 30, 2026Common StockOption exercise15,881US$72.34582,564Direct
Oct 30, 2026Common StockSale15,881US$175.25566,683Direct
Nov 2, 2026Common StockSale1,600US$167.40565,083Direct
Nov 2, 2026Common StockSale1,700US$168.10563,383Direct
Nov 2, 2026Common StockSale1,904US$169.27561,479Direct
Nov 2, 2026Common StockSale7,796US$170.35553,683Direct
Nov 2, 2026Common StockSale2,000US$171.06551,683Direct

Source

Download original · View original at SEC

Related